MEMORANDUM OF UNDERSTANDING
This Memorandum of Understanding ("MOU") is entered into on this 18th day of October, 2024 ("Effective Date"), by and between:
PharmaGenix Ltd.
456, Industrial Estate
Hyderabad, India 500089
Represented by: Dr. K. S. Rao, CEO
University of Life Sciences
ULS Campus, Gachibowli
Hyderabad, India 500032
Represented by: Prof. Vijay Kumar, Vice Chancellor
RECITALS
WHEREAS, PharmaGenix Ltd. ("PGL") specializes in pharmaceutical research and development; and
WHEREAS, University of Life Sciences ("ULS") has expertise in life sciences research.
ARTICLE 1: PURPOSE AND SCOPE
1.1 The purpose of this MOU is to establish a joint innovation lab for drug development.
1.2 The scope of this MOU includes:
Facility sharing arrangements
Resource contributions
Project timelines and milestones
Ownership of intellectual property
ARTICLE 2: FACILITY SHARING ARRANGEMENTS
2.1 ULS shall provide laboratory space and equipment.
2.2 PGL shall provide additional equipment and resources as needed.
ARTICLE 3: RESOURCE CONTRIBUTIONS
3.1 PGL shall contribute:
₹50 lakhs per annum for 3 years
2 full-time researchers
3.2 ULS shall contribute:
₹25 lakhs per annum for 3 years
3 faculty members
ARTICLE 4: PROJECT TIMELINES AND MILESTONES
4.1 Project duration: 3 years
4.2 Milestones:
Month 6: Completion of feasibility study
Month 12: Completion of prototype development
Month 24: Completion of clinical trials
ARTICLE 5: OWNERSHIP OF INTELLECTUAL PROPERTY
5.1 Ownership: All intellectual property rights arising from the joint research shall be jointly owned by PGL and ULS.
5.2 Commercialization: PGL shall have the first right to commercialize any resulting products.
5.3 Royalty: ULS shall receive a royalty of 5% on net sales of commercialized products.
ARTICLE 6: DURATION AND TERMINATION
6.1 This MOU shall remain in effect for 3 years from the Effective Date.
6.2 Either Party may terminate this MOU with 30 days' written notice.
ARTICLE 7: CONFIDENTIALITY
7.1 The Parties agree to keep confidential all information exchanged under this MOU.
7.2 The Parties shall not disclose confidential information to any third party without prior written consent.
ARTICLE 8: GOVERNING LAW
8.1 This MOU shall be governed by and construed in accordance with the laws of India.
8.2 Any disputes arising from this MOU shall be resolved through arbitration.
IN WITNESS WHEREOF
The Parties have executed this MOU as of the date first above written.
---
PharmaGenix Ltd.
By: Dr. K. S. Rao
Title: CEO
Date: 18th October 2024
---
University of Life Sciences
By: Prof. Vijay Kumar
Title: Vice Chancellor
Date: 18th October 2024
